发明名称 |
Methods of using bi-specific antibodies for treating B-cell-mediated autoimmune diseases or auto-reactive B-cells |
摘要 |
A bispecific antibody format devoid of an active Fc moiety comprising a monovalent binding site for a death receptor and at least one binding site for a cell surface antigen expressed on B-cells, for use in the treatment or prevention of B cell mediated autoimmune diseases. |
申请公布号 |
US9624310(B2) |
申请公布日期 |
2017.04.18 |
申请号 |
US201214358797 |
申请日期 |
2012.11.19 |
申请人 |
Jung Gundram |
发明人 |
Jung Gundram;Grosse-Hovest Ludger |
分类号 |
C07K16/46;C07K16/28;A61K39/395 |
主分类号 |
C07K16/46 |
代理机构 |
Meunier Carlin & Curfman LLC |
代理人 |
Meunier Carlin & Curfman LLC |
主权项 |
1. A method for the treatment of a B-cell-mediated autoimmune disease comprising administering a therapeutically effective amount of a bispecific antibody devoid of an active Fc moiety, wherein the antibody comprises a monovalent binding site for a B-cell CD95 death receptor and at least one binding site for a cell surface antigen expressed on B-cells to a subject in need thereof, wherein the cell surface antigen is selected from the group consisting of CD19, CD20 and CD40. |
地址 |
Rottenburg-Wendelsheim DE |